Sign in
4

Changes in Ownership

Caris Life Sciences, Inc. Filed Acc 0002071953-26-000007

President sold 597,212 shares at an average $24.84 ($14,834,107)

  • President acquired 1,250,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Spetzler David Baxley President 2026-09-03 Option exercise +1,000,000 $2.44 $2,440,000 1,530,083 D: show line 1 in the form
Spetzler David Baxley President 2026-09-03 Sale −393,100 $24.76 $9,733,313 1,136,983 D: show line 2 in the form
Spetzler David Baxley President 2026-09-03 Sale −84,900 $25.32 $2,149,676 1,052,083 D: show line 3 in the form
Spetzler David Baxley President 2026-09-04 Option exercise +250,000 $2.44 $610,000 1,302,083 D: show line 4 in the form
Spetzler David Baxley President 2026-09-04 Sale −119,212 $24.76 $2,951,117 1,182,871 D: show line 5 in the form
Open-market sales · 597,212 sh · avg $24.84 · $14,834,107

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Spetzler David Baxley President 2026-09-03 Option exercise · Stock Option −1,000,000 250,000 D: show line 6 in the form
Spetzler David Baxley President 2026-09-04 Option exercise · Stock Option −250,000 0 D: show line 7 in the form
Loading xslF345X06/wk-form4_1788555596.xml…